Tyrosine kinases as targets for cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tyrosine kinases as targets for cancer therapy

Published:2002-09 Issue: Volume:38 Page:S11-S18
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Levitzki Alexander

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference52 articles.

1. Tyrphostins — potential antiproliferative agents and novel molecular tools;Levitzki;Biochem Pharmacol,1990

2. Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors;Yaish;Science,1988

3. Signal-transduction therapy;Levitzki;Eur J Biochem,1994

4. Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors;Gazit;J Med Chem,1989

5. Tyrphostins: tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction;Levitzki;FASEB J,1992

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NT157 as an Anticancer Drug Candidate That Targets Kinase- and Phosphatase-Mediated Signaling;Kinases and Phosphatases;2024-05-29

2. Molecular authentication, metabolite profiling and in silico–in vitro cytotoxicity screening of endophytic Penicillium ramusculum from Withania somnifera for breast cancer therapeutics;3 Biotech;2024-02-09

3. 9,10-Dioxoanthracenyldithiocarbamates effectively inhibit the proliferation of non-small cell lung cancer by targeting multiple protein tyrosine kinases;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-12-11

4. New theobromine derivative as apoptotic anti-triple-negative breast cancer targeting EGFR protein: CADD story;Journal of Molecular Structure;2023-12

5. Novel 7-Deazapurine Incorporating Isatin Hybrid Compounds as Protein Kinase Inhibitors: Design, Synthesis, In Silico Studies, and Antiproliferative Evaluation;Molecules;2023-08-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3